Literature DB >> 6140517

Resistant Shigella dysenteriae.

B R Panhotra, B Desai.   

Abstract

Mesh：

Substances：

Year:  1983        PMID： 6140517     DOI： 10.1016/s0140-6736(83)90947-9

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  6 in total

1.  Which chemotherapy for shigella dysentery?

Authors:  G Bhardwaj; B R Panhotra
Journal:  Indian J Pediatr       Date:  1985 Sep-Oct       Impact factor: 1.967

2.  Comparison of norfloxacin and nalidixic acid for treatment of dysentery caused by Shigella dysenteriae type 1 in adults.

Authors:  F Rogerie; D Ott; J Vandepitte; L Verbist; P Lemmens; I Habiyaremye
Journal:  Antimicrob Agents Chemother       Date:  1986-05       Impact factor: 5.191

3.  Monitoring of antibiotic resistance in shigellae isolated in The Netherlands 1984-1989.

Authors:  C E Voogd; C S Schot; W J van Leeuwen; B van Klingeren
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-02       Impact factor: 3.267

4.  Plasmid characterization of drug-resistant Shigella dysenteriae 1 from an epidemic in Central Africa.

Authors:  J A Frost; G A Willshaw; E A Barclay; B Rowe; P Lemmens; J Vandepitte
Journal:  J Hyg (Lond)       Date:  1985-04

5.  Emerging nalidixic acid and ciprofloxacin resistance in non-typhoidal Salmonella isolated from patients having acute diarrhoeal disease.

Authors:  B R Panhotra; A K Saxena; Ali M Al-Arabi Al-Ghamdi
Journal:  Ann Saudi Med       Date:  2004 Sep-Oct       Impact factor: 1.526

6.  Emerging nalidixic acid and ciprofloxacin resistance in non-typhoidal Salmonella isolated from patients having acute diarrhoeal disease.

Authors:  B R Panhotra; A K Saxena; Ali M Al-Arabi Al-Ghamdi
Journal:  Ann Saudi Med       Date:  2004 Jul-Aug       Impact factor: 1.526
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.